183 related articles for article (PubMed ID: 14615291)
1. Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction.
Bueno OF; Lips DJ; Kaiser RA; Wilkins BJ; Dai YS; Glascock BJ; Klevitsky R; Hewett TE; Kimball TR; Aronow BJ; Doevendans PA; Molkentin JD
Circ Res; 2004 Jan; 94(1):91-9. PubMed ID: 14615291
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase.
Obasanjo-Blackshire K; Mesquita R; Jabr RI; Molkentin JD; Hart SL; Marber MS; Xia Y; Heads RJ
Cardiovasc Res; 2006 Sep; 71(4):672-83. PubMed ID: 16828070
[TBL] [Abstract][Full Text] [Related]
4. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.
Pu WT; Ma Q; Izumo S
Circ Res; 2003 Apr; 92(7):725-31. PubMed ID: 12663489
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
6. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
[TBL] [Abstract][Full Text] [Related]
7. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
8. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway.
Rana OR; Saygili E; Meyer C; Gemein C; Krüttgen A; Andrzejewski MG; Ludwig A; Schotten U; Schwinger RH; Weber C; Weis J; Mischke K; Rassaf T; Kelm M; Schauerte P
J Mol Cell Cardiol; 2009 Apr; 46(4):568-78. PubMed ID: 19150448
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury.
Zhou X; Fan GC; Ren X; Waggoner JR; Gregory KN; Chen G; Jones WK; Kranias EG
Cardiovasc Res; 2007 Aug; 75(3):487-97. PubMed ID: 17499229
[TBL] [Abstract][Full Text] [Related]
10. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
Wilkins BJ; Molkentin JD
Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
[TBL] [Abstract][Full Text] [Related]
11. MK2-/- gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury.
Shiroto K; Otani H; Yamamoto F; Huang CK; Maulik N; Das DK
J Mol Cell Cardiol; 2005 Jan; 38(1):93-7. PubMed ID: 15623425
[TBL] [Abstract][Full Text] [Related]
12. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
13. Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury.
Stephanou A
Eur Cytokine Netw; 2002; 13(4):401-3. PubMed ID: 12517719
[TBL] [Abstract][Full Text] [Related]
14. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury.
Brocheriou V; Hagège AA; Oubenaïssa A; Lambert M; Mallet VO; Duriez M; Wassef M; Kahn A; Menasché P; Gilgenkrantz H
J Gene Med; 2000; 2(5):326-33. PubMed ID: 11045426
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.
Bao W; Hu E; Tao L; Boyce R; Mirabile R; Thudium DT; Ma XL; Willette RN; Yue TL
Cardiovasc Res; 2004 Feb; 61(3):548-58. PubMed ID: 14962485
[TBL] [Abstract][Full Text] [Related]
16. Smad1 protects cardiomyocytes from ischemia-reperfusion injury.
Masaki M; Izumi M; Oshima Y; Nakaoka Y; Kuroda T; Kimura R; Sugiyama S; Terai K; Kitakaze M; Yamauchi-Takihara K; Kawase I; Hirota H
Circulation; 2005 May; 111(21):2752-9. PubMed ID: 15911698
[TBL] [Abstract][Full Text] [Related]
17. Heat shock transcription factor 1 protects cardiomyocytes from ischemia/reperfusion injury.
Zou Y; Zhu W; Sakamoto M; Qin Y; Akazawa H; Toko H; Mizukami M; Takeda N; Minamino T; Takano H; Nagai T; Nakai A; Komuro I
Circulation; 2003 Dec; 108(24):3024-30. PubMed ID: 14623809
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
Echtermeyer F; Harendza T; Hubrich S; Lorenz A; Herzog C; Mueller M; Schmitz M; Grund A; Larmann J; Stypmann J; Schieffer B; Lichtinghagen R; Hilfiker-Kleiner D; Wollert KC; Heineke J; Theilmeier G
Cardiovasc Res; 2011 Oct; 92(1):123-31. PubMed ID: 21632883
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J
Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920
[TBL] [Abstract][Full Text] [Related]
20. Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heart.
Schwarz ER; Tussing T; Skobel E; Klosterhalfen B; Domanski D; Fuess JE
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):215-21. PubMed ID: 19605571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
